This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CYRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Alphabet (GOOGL) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ur Energy (URG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
URGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Envista (NVST)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NVSTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Robinhood's Lofy Valuation: A Vote of Confidence or Cautionary Tale?
by Swayta Shah
HOOD trades at a steep premium. Can bold global moves, crypto growth and diversification justify the price? Let's have a look.
SCHWNegative Net Change IBKRNegative Net Change HOODNegative Net Change
fin-tech finance
How's MELI Using Argentina's Economic Recovery to Fuel its Growth?
by Zacks Equity Research
MercadoLibre rides Argentina's economic rebound with booming revenues, cross-border expansion, and bold fintech ambitions.
AMZNNegative Net Change MELIPositive Net Change DLONegative Net Change
fin-tech retail
SoFi is Playing to Win and Not Backing Down From the Fintech Fight
by Zacks Equity Research
SOFI's net income surges 217% as it doubles down on innovation, partnerships, and fee-based growth amid fierce fintech rivalry.
UPSTNegative Net Change SOFINegative Net Change XYZNegative Net Change
fin-tech finance
Can StoneCo's Software Divestment Unlock MSMB-Focused Growth?
by Moumita C. Chattopadhyay
StoneCo's sale of major software assets sharpens its MSMB focus as bundling, PIX and deposits drive momentum.
STNENegative Net Change MELIPositive Net Change PAGSNegative Net Change
artificial-intelligence fin-tech
Mastercard vs. PayPal: Which Payments Innovator is the Better Buy Now?
by Kaibalya Pravo Dey
PayPal's lower valuation, direct commerce and lower leverage could make it the better buy over Mastercard now.
MANegative Net Change PYPLNegative Net Change
business-services fin-tech finance payments
PayPal Taps New Markets: Will Interoperability Fuel Its Growth?
by Moumita C. Chattopadhyay
PYPL's new global platform links nearly 2B users and wallets, aiming to redefine cross-border commerce and payments.
PYPLNegative Net Change VNegative Net Change GPNNegative Net Change
artificial-intelligence fin-tech
Coherent (COHR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
COHRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Preferred Bank (PFBC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PFBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
BILL vs. Intuit: Which Fintech Powerhouse Stock Is the Smarter Buy?
by Nilanshi Mukherjee
INTU surges ahead with strong earnings and an expanding SMB ecosystem, while BILL Holdings battles headwinds despite innovation gains.
INTUNegative Net Change BILLNegative Net Change
artificial-intelligence automation fin-tech tech-stocks
Enterprise Suite and Agentic AI: Can Intuit Win Mid-Market?
by Moumita C. Chattopadhyay
INTU rolls out AI agents in its Enterprise Suite, targeting mid-market firms with smarter, automated operations.
INTUNegative Net Change PAYXNegative Net Change ORCLNegative Net Change
fin-tech
Arista Networks (ANET) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ANETNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Figs (FIGS)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FIGSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, GXO Logistics (GXO)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GXONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Anywhere Real Estate (HOUS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HOUSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Synovus Financial (SNV)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SNVNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Discover Deal Boosts COF's Q2 Earnings, Consumer Spending in Focus
by Zacks Equity Research
Capital One tops Q2 earnings estimates as the Discover deal boosts card loans, NII and fee income.
COFNegative Net Change ALLYNegative Net Change NAVINegative Net Change
banking earnings fin-tech finance
COF Up on Q2 Earnings Beat, Discover Deal Boosts NII and Fee Income
by Zacks Equity Research
Capital One stock jumps 4% after Q2 earnings crush estimates. The Discover deal lifts NII and fee income despite rising costs and provisions.
COFNegative Net Change ALLYNegative Net Change NAVINegative Net Change
banking earnings fin-tech finance
The Zacks Analyst Blog Highlights Visa and Affirm Holdings
by Zacks Equity Research
AFRM's surging growth, global expansion, and BNPL momentum challenge V's dominance in a rapidly evolving payments space.
VNegative Net Change AFRMNegative Net Change
fin-tech
Finding the Best Cheap Stocks to Buy Now
by Benjamin Rains
Investors who want to keep buying stocks in July and throughout the second half of 2025 might consider adding exposure to highly-ranked cheap stocks that trade for $10 a share or less.
PAYSNegative Net Change
fin-tech finance
Block Stock Rises 24.7% in a Month: What This Means for Investors
by Zacks Equity Research
XYZ's 24.7% stock surge and S&P 500 debut highlight its fintech strength and growing investor confidence.
TTDNegative Net Change RDDTPositive Net Change XYZNegative Net Change
fin-tech
Visa vs. Affirm: Old Guard or Fintech Fire - Who Wins the Payment War?
by Kaibalya Pravo Dey
AFRM surges with 127.5% gains and 101.8% EPS growth forecast. Can its BNPL model outpace V's global payments dominance?
VNegative Net Change AFRMNegative Net Change
fin-tech finance payments